Mitochondrial estrogen receptors alter mitochondrial priming and response to endocrine therapy in breast cancer cells

Breast cancer is the most common cancer with a high rate of mortality and morbidity among women worldwide. Estrogen receptor status is an important prognostic factor and endocrine therapy is the choice of first-line treatment in ER-positive breast cancer. However, most tumors develop resistance to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakas, Bahriye, Aka, Yeliz, Giray, Asli, Temel, Sehime Gulsun, Acikbas, Ufuk, Basaga, Huveyda, Gul, Ozgur, Kutuk, Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298581/
https://www.ncbi.nlm.nih.gov/pubmed/34294688
http://dx.doi.org/10.1038/s41420-021-00573-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298581/
https://www.ncbi.nlm.nih.gov/pubmed/34294688
http://dx.doi.org/10.1038/s41420-021-00573-2

Ejemplares similares